| 主題 | 分類 |
|---|
Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial
肝癌
文獻出處：Cancer Immunology, Immunotherapy volume 70, pages945–957(2021)
Prognostic Significance of Adoptive Immunotherapy with Tumor-associated Lymphocytes in Patients with Advanced Gastric Cancer：A Randomized Trial
胃癌
文獻出處：Clin Cancer Res. 8:1767-1771. (2002)
Randomized controlled phase III trial of adjuvant chemo‑immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
肺癌
文獻出處：Cancer Immunol Immunother.64:51–59.(2015)
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
膽管癌
文獻出處：J Hepatobiliary Pancreat Sci. 19:171–178.(2012)
Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
肺癌
文獻出處：Cancer Immunol Immunother.65(9):1099-111.(2016)
Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
肝癌
文獻出處：Hum Vaccin Immunother.10(4):970-6.(2014)
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
卵巢癌
文獻出處：Journal of Ovarian Research.7:48-56.(2014)
Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
胰臟癌
文獻出處：Cancer Immunology, Immunotherapy.63(8):797-806.(2014)